about
A direct binding site for Grb2 contributes to transformation and leukemogenesis by the Tel-Abl (ETV6-Abl) tyrosine kinaseUbp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptor signalingOncogenic kinase fusions: an evolving arena with innovative clinical opportunitiesHsp90 Inhibitors for the Treatment of Chronic Myeloid LeukemiaThe Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues.Studying the pathogenesis of BCR-ABL+ leukemia in mice.Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemiaLeukemia stem cells in a genetically defined murine model of blast-crisis CML.Aberrant cytokine signaling in leukemia.Proteasome inhibition causes regression of leukemia and abrogates BCR-ABL-induced evasion of apoptosis in part through regulation of forkhead tumor suppressors.Production of replication-defective retrovirus by transient transfection of 293T cells.Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice.Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia.Murine retroviral bone marrow transplantation models for the study of human myeloproliferative disorders.Establishment and phenotypic characterization of human U937 cells with inducible P210 BCR/ABL expression reveals upregulation of CEACAM1 (CD66a).CML Mouse Model Generated from Leukemia Stem Cells.
P2860
Q24563301-D85E180B-0C21-4776-8968-9E29281B8FDFQ24685070-32D3393D-2DC2-4294-894D-E22F629FFAC1Q26768158-798C4BA5-8ADA-4A68-BE90-B3ACB5A7562BQ26771790-874A34F7-2A0D-49C5-870F-E81A1EA8FEE3Q34750582-9012B7EA-D69D-41D6-9234-BEC381B880A4Q35022543-AE63E4D4-AA32-428F-B653-EDDE8180CB7AQ35409569-1E84F58A-D484-4A27-A11F-62F4BBFF48CFQ36007673-DCF3408F-9621-48C9-84F6-7B2398B336A1Q36970192-39283D9D-C1A6-4CA9-B00A-64619B4053B6Q37390575-74668CEB-6CEC-4CB8-9B03-59F939212253Q39920432-BB6F5FF9-BB70-4D77-961B-236040F0DFC7Q40230301-09DA7B5D-F3CF-4E2A-BFA5-4CD42E80D3CBQ42089534-B98CE5CB-64DA-45B5-827D-B3C895641C23Q42721777-A0851BAA-7BFB-4495-8DF0-E28E07FAA5C6Q44719689-1232A9D9-BFB3-4A58-9BF4-9383C1E2B96DQ55016663-DB101C23-8B29-4993-8592-040C01BE0577
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Models of chronic myeloid leukemia.
@ast
Models of chronic myeloid leukemia.
@en
Models of chronic myeloid leukemia.
@nl
type
label
Models of chronic myeloid leukemia.
@ast
Models of chronic myeloid leukemia.
@en
Models of chronic myeloid leukemia.
@nl
prefLabel
Models of chronic myeloid leukemia.
@ast
Models of chronic myeloid leukemia.
@en
Models of chronic myeloid leukemia.
@nl
P2860
P1476
Models of chronic myeloid leukemia.
@en
P2093
Van Etten RA
P2860
P2888
P304
P356
10.1007/S11912-001-0055-Y
P577
2001-05-01T00:00:00Z
P6179
1050015742